Last Man Standing in Indian Pharma

Last Man Standing in Indian Pharma Glenn Saldanha looks like a man at peace. The turmoil within the pharmaceutical industry–pipelines running dry, mergers and acquisitions in the hope of new discovery and an emerging question mark on investing in innovation–seems distant for the managing director and CEO of Glenmark Pharmaceuticals. At 41, he is pretty much in control of the task he set out to do a decade ago: Turning Glenmark into a multinational company that makes innovative drugs, and not just the generic drugs it has been developing for 23 years. In an assertion of the belief that the Read More

ˆ Back To Top